LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Causes of Shoulder Arthroplasty Hospital Readmissions
Large Joints and Extremities

Causes of Shoulder Arthroplasty Hospital Readmissions

May 5, 2022 1 min read Premium comments

Advertisement

#comorbiditiesSecondary#glenohumeralosteoarthritis#totalshoulderarthroplasty

For patients with glenohumeral osteoarthritis, hospital readmission after total shoulder arthroplasty is more likely if they have greater comorbidities, a new study finds.

The study, “Comparison of patient-demographics, causes, and costs of 90-day readmissions following primary total shoulder arthroplasty for glenohumeral osteoarthritis,” was published in the May-June 2022 issue of The Journal of Orthopaedics.

“Readmissions following orthopaedic surgery are associated with worse outcomes and increased healthcare costs. Studies investigating trends, causes, and costs of readmissions following primary total shoulder arthroplasty for the indication of glenohumeral osteoarthritis are limited,” the researchers wrote.

For their study, the research team compared and contrasted the patient-demographics of those who were readmitted within 90-days of a primary shoulder arthroplasty and those who were not. Among the data collected were causes for readmission and the related costs.

The team then gathered data retrospectively from 2005 to 2014 using a nationwide administrative claims database. Causes of readmission were broken down into the following groups: cardiovascular, hematological, endocrine, gastrointestinal, musculoskeletal, neoplastic, neurological, pulmonary, infectious, renal, and miscellaneous causes.

The team discovered that the patients more likely to be readmitted were those over the age of 75 with a higher prevalence of comorbid conditions, including psychiatric and medical conditions. They are also more likely to be female.

The overall 90-day readmission rate was 2.4% (3,432/143,878). Readmitted patients had a higher overall comorbidity burden per mean Elixhauser-Comorbidity Index scores (10 vs. 7, p < .0001). The leading cause of readmissions were due to musculoskeletal (17.34%), cardiac (16.28%), infectious (16.26%), and gastrointestinal (11.64%) complications.

The researchers said there were differences in the mean 90-day cost of care between the difference reasons for readmission. The most expensive causes were cardiac ($10,913.70) and musculoskeletal ($10,590.50).

Advertisement

“Patients with greater comorbidities experienced increased incidence of readmission following total shoulder arthroplasty for glenohumeral osteoarthritis. Cardiac and musculoskeletal etiologies were the primary cause of readmission,” the researchers wrote.

Study authors include Marcos Vargas, Giovanni Sanchez, Adam M. Gordon, Andrew R. Horn, Charles A. Conway, Afshin E. Razi and Ramin Sadeghpour, all of Maimonides Medical Center.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy